Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1993-12-23
pubmed:abstractText
[125I]RTI-55 is a newly synthesized cocaine congener that may offer advantages over other ligands previously used to examine cocaine binding sites. However, the in vitro pharmacological and anatomical characterization of [125I]RTI-55 binding sites has not been previously performed in human brain. To determine the specificity, stability, and feasibility of [125I]RTI-55 for use in radioligand binding assays in postmortem human tissue, a series of experiments were performed characterizing [125I]RTI-55 binding sites in human brain using homogenized membrane preparations and quantitative autoradiography. Analysis of the association, dissociation, and saturation data favored two-phase processes. A curve-fitting analysis of the data derived in saturation experiments found a high-affinity site with KD = 66 +/- 35 pM and Bmax = 13.2 +/- 10.1 pmol/g of tissue and a low-affinity site with KD = 1.52 +/- 0.55 nM and Bmax of 47.5 +/- 11.2 pmol/g of tissue. Competition by ligands known to bind to the dopamine transporter showed a rank order of RTI-55 > GBR-12909 > maxindol > WIN 35428 > = methylphenidate > (-)-cocaine > buproprion > (+)-amphetamine. Binding to serotonergic sites was evaluated in the midbrain. Results of the saturation experiment performed autoradiographically in the midbrain showed a single site with KD = 370 +/- 84 pM. It appears that [125I]RTI-55 should be useful in further studies of the regulation of cocaine binding sites using postmortem human specimens.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1996-2006
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8245956-Adult, pubmed-meshheading:8245956-Autoradiography, pubmed-meshheading:8245956-Binding, Competitive, pubmed-meshheading:8245956-Binding Sites, pubmed-meshheading:8245956-Carrier Proteins, pubmed-meshheading:8245956-Caudate Nucleus, pubmed-meshheading:8245956-Cell Membrane, pubmed-meshheading:8245956-Cocaine, pubmed-meshheading:8245956-Corpus Striatum, pubmed-meshheading:8245956-Dopamine, pubmed-meshheading:8245956-Dopamine Plasma Membrane Transport Proteins, pubmed-meshheading:8245956-Female, pubmed-meshheading:8245956-Humans, pubmed-meshheading:8245956-Iodine Radioisotopes, pubmed-meshheading:8245956-Kinetics, pubmed-meshheading:8245956-Male, pubmed-meshheading:8245956-Membrane Glycoproteins, pubmed-meshheading:8245956-Membrane Transport Proteins, pubmed-meshheading:8245956-Middle Aged, pubmed-meshheading:8245956-Nerve Tissue Proteins, pubmed-meshheading:8245956-Serotonin, pubmed-meshheading:8245956-Serotonin Plasma Membrane Transport Proteins
pubmed:year
1993
pubmed:articleTitle
[125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
pubmed:affiliation
Department of Psychiatry, University of North Carolina at Chapel Hill.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't